+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Roche Diagnostics Ltd. - logo

Founded in Basel, Switzerland in 1896, Roche produces innovative medicines and diagnostic tests for the early detection, prevention, diagnosis and treatment of diseases including oncology, rheumatology, virology, transplantation, diabetes and immunology. They are the world’s leading biotech company and have been at the forefront of cancer research and treatment for more than 50 years, in addition to being the leading provider of in vitro diagnostics.

Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Nasopharyngeal Cancer Market Report and Forecast 2024-2032 - Product Thumbnail Image

Nasopharyngeal Cancer Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Synovial Sarcoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Synovial Sarcoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Neuroendocrine Carcinoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Neuroendocrine Carcinoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Ophthalmic Drugs Market Report 2025-2035 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2025-2035

  • Report
  • December 2024
  • 340 Pages
  • Global
From
2024 Germany Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Product Thumbnail Image

2024 Germany Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Report
  • August 2024
  • 283 Pages
  • Germany
From
2024 France Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Product Thumbnail Image

2024 France Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Report
  • August 2024
  • 282 Pages
  • France
From
2024 USA Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia - Product Thumbnail Image

2024 USA Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • Report
  • August 2024
  • 322 Pages
  • United States
From
2024 UK Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia - Product Thumbnail Image

2024 UK Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • Report
  • August 2024
  • 322 Pages
  • United Kingdom
From
2024 Spain Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia - Product Thumbnail Image

2024 Spain Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • Report
  • August 2024
  • 322 Pages
  • Spain
From
2024 Japan Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia - Product Thumbnail Image

2024 Japan Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • Report
  • August 2024
  • 322 Pages
  • Japan
From
2024 Italy Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia - Product Thumbnail Image

2024 Italy Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • Report
  • August 2024
  • 322 Pages
  • Italy
From
2024 Germany Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia - Product Thumbnail Image

2024 Germany Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • Report
  • August 2024
  • 322 Pages
  • Germany
From
2024 France Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia - Product Thumbnail Image

2024 France Enteric Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • Report
  • August 2024
  • 322 Pages
  • France
From
2024 USA Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Product Thumbnail Image

2024 USA Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Report
  • August 2024
  • 283 Pages
  • United States
From
2024 UK Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Product Thumbnail Image

2024 UK Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Report
  • August 2024
  • 281 Pages
  • United Kingdom
From
2024 Spain Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Product Thumbnail Image

2024 Spain Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Report
  • August 2024
  • 281 Pages
  • Spain
From
2024 Japan Respiratory Disease Molecular Diagnostics Market Shares: and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Product Thumbnail Image

2024 Japan Respiratory Disease Molecular Diagnostics Market Shares: and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Report
  • August 2024
  • 282 Pages
  • Japan
From
2024 Italy Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Product Thumbnail Image

2024 Italy Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Report
  • August 2024
  • 281 Pages
  • Italy
From
2024 Succeeding in the Pharmaceutical Market: Supplier Strategies and Capabilities - Product Thumbnail Image

2024 Succeeding in the Pharmaceutical Market: Supplier Strategies and Capabilities

  • Report
  • January 2024
  • Global
From
Loading Indicator